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The full-length human androgen receptor with an N-terminal biotin acceptor peptide tag was overexpressed
in Spodoptera frugiperda cells in the presence of 1 µM dihydrotestosterone. Site-specific biotinylation of BAP
was achieved in vivo by co-expression of E. coli biotin holoenzyme synthetase.The androgen receptor was
purified by single-step affinity chromatography using Streptavidin Mutein Matrix under native conditions.The
resultant protein was active, stable, 95% homogeneous, and we obtained sufficient yield for use in functional
and structural studies.
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Introduction
The androgen receptor (AR) is a ligand-activated
transcription factor and a member of the nuclear receptor
superfamily [Mi and Rastinejad, 2001; Evans, 1988] .
Consistent with other nuclear receptors, AR consists of
four functionally and structurally distinct domains: the
N-terminal transactivation domain, DNA binding domain
(DBD), hinge region, and C-terminal ligand-binding
domain (LBD) [McEwan, 2004] . Androgens, such as
testosterone and dihydrotestosterone (DHT), bind with
high affinity to AR, resulting in a distinct conformational
change in the receptor LBD. After ligand binding, AR
translocates to the nucleus, binds specific DNA response
elements located in target promoters, and regulates genes
that are essential for the development of the male
phenotype [Wilson et al., 1991] . Several mutations in the
AR gene are linked to human disease, including androgen
insensitivity syndrome, prostate cancer, and spinal and
bulbar muscular atrophy (SBMA), thus validating AR as
a major therapeutic target [Heinlein and Chang, 2004;
McPhaul, 2002; Poletti, 2004] .
Functional and structural studies of AR require large
amounts of homogeneous protein. Purification of AR, as
with other nuclear receptors, is complicated due to
insolubility, instability, low abundance, and problems with
aggregation.Various approaches have been taken to
solve these problems, including the use of different affinity
tags for the overexpression of recombinant full-length AR
or AR domains in bacterial [Roehrborn et al., 1992] ,
insect [Liao and Wilson, 2001; Chang et al., 1992; Zhu
et al., 2001] , or mammalian cell [Quarmby et al., 1990]
expression systems as well as purification under native
or denaturing conditions. Most of these expression and
purification protocols have many disadvantages including
low yield and purity, solubility and stability issues, and
lack of post-translational modifications. In addition,
denaturing conditions may interfere with protein folding,
thereby affecting receptor activity.
In this article we describe a rapid, single-step purification
protocol that yields 95% homogeneous full-length AR
protein from Sf9 cells.We employ technology that allows
the biotin-labeling of recombinant hAR in Sf9 cells [Duffy
et al., 1998] . Affinity chromatography is then used to
purify AR under native conditions based on the interaction
of biotin and streptavidin. Streptavidin Mutein Matrix
(Roche Applied Science, Indianapolis, IN, USA) is used
for the purification of AR.This high-performance resin
demonstrates low nonspecific binding, high protein purity,
and efficient recovery.This purification protocol is likely
to be applicable to a wide range of proteins, including
other full-length nuclear receptors.
Reagents and Instruments
pDW464 plasmid was purchased from ScienceReagents,
Inc. (El Cajon, CA). Bac-to-Bac® Baculovirus Expression
System, PBS, Sf-900 II Serum-Free Medium (SFM),
NuPage® Novex® Bis-Tris gels, BL21(DE3)pLysS cells,
pDEST-15 vector, MagicMark™Western standards were
purchased from Invitrogen Corporation (Carlsbad, CA).
Dihydrotestosterone (DHT) was bought from
Sigma-Aldrich (St.Louis, MO). Protease Inhibitor Cocktail
Set III came from Calbiochem (San Diego, CA).
Streptavidin Mutein Matrix was purchased from Roche
Applied Science (Indianapolis, IN). Chromatography was
performed on an ÄKTA™ purifier Amersham Biosciences
Corp. (Piscataway, NJ) using a Tricorn™ 5/50 column
(Amersham Biosciences Corp). Criterion™ XT gels,
Precision Plus protein standards were from Bio-Rad
Laboratories (Hercules, CA). Streptavidin-horseradish
peroxidase conjugate, Glutathione Sepharose™ 4 Fast
Flow, pGEX-5X-1 plasmid came from Amersham
Biosciences. D-biotin, NeutrAvidin, SuperSignal® West
Pico kit, MemCode™ Reversible Protein Stain kit were
purchased from Pierce Biotechnology, Inc (Rockford, IL).
Costar® 96 well plates were from Corning, Inc (Corning,
NY). Microson XL 2000 sonicator was bought from
Misonix (Farmingdale, NY).
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Construction of recombinant shuttle vector
pDW464/hAR and recombinant baculovirus
Full-length (1-924) human androgen receptor cDNA was
subcloned into the pDW464 plasmid which is designed
to produce biotinylated proteins in S. frugiperda cells
[Duffy et al., 1998] .The plasmid encodes E. coli biotin
holoenzyme synthetase (BirA), which site-specifically
biotinylates the biotin acceptor peptide (BAP, 23 amino
acids). Recombinant baculoviruses were generated by
recombination of pDW464/hAR with baculovirus DNA in
vivo using the Bac-to-Bac® baculovirus expression
system.
Expression of hAR in Sf9 cells
Sf9 cells were cultivated in 200 ml of Sf-900 II Serum-free
medium (SFM) as a suspension culture at 27°C.The cells
were infected with recombinant baculovirus at a density
of 2 X 106 cells/ml. Androgen receptor ligand DHT (1 µM
final concentration) was added after 24 hours and cells
were incubated for an additional 24 hours. Cells were
harvested by centrifugation and stored at -80°C.
Figure 1. Western blot of AR batch purification using Streptavidin
Mutein Matrix under different binding conditions. M: Markers; lanes
1-9: binding in the absence of (NH4)2SO4 ; lanes 10-18: binding in the
presence of 0.4M (NH4)2SO4 ; lanes 1and 10: nuclear-extract fraction
before purification; lanes 2 and 11: flow-through; lanes 3-5 and 12-14:
washes; lanes 6-8 and 15-17: elutions; lanes 9 and 18: beads. 2.5 µl of
each fraction was loaded in lanes 1, 2, 10, and 11, and 15 µl was loaded
in all other lanes.
Preparation of nuclear extract from Sf9 cells
Sf9 cells derived from one liter of culture were thawed
and resuspended on ice in 100 ml hypotonic buffer: 10
mM Tris-HCl, pH 8.0, 10 mM NaCl, 1.5 mM MgCl2, 10
mM β-mercaptoethanol, 1 µM DHT, and 1/200 ml of
Protease Inhibitor Cocktail Set III.The suspension was
transferred to an ice-cold Dounce homogenizer, incubated
for 15 minutes on ice, and lysed with 25 strokes. After
centrifugation at 7,000X g for 10 minutes at 4°C, the
supernatant containing the cytoplasmic fraction was
discarded and the pellet was resuspended in 30 ml
nuclear-extract buffer: 10 mM Tris-HCl, pH 8.0, 0.3 M
NaCl, 1.5 mM MgCl2, 10 mM β-mercaptoethanol, 50 mM
β-glycerophosphate, 50 mM NaF, 1 µM DHT, and 1/200
ml protease inhibitor cocktail set III.The nuclear-extract
fraction was incubated for 30 minutes at 4°C with rotation,
then clarified by centrifugation at 50,000X g for 30 minutes
at 4°C.The supernatant was transferred to a clean chilled
tube after filtration through a 0.45 µm filter.
Batch purification of hAR using Streptavidin
Mutein Matrix
Batch purification was performed according to the
manufacturer’s instructions. Briefly, 100 µl of Streptavidin
Mutein Matrix gel slurry, corresponding to 50 µl packed
gel, was suspended in equilibration buffer: 100 mM
potassium phosphate, pH 7.2, 0.15 M NaCl in the
presence or absence of 0.4 M (NH4)2SO4. After
equilibration, 50 µl of Streptavidin Mutein Matrix (gel bed
volume) was incubated with 400 µl of nuclear-extract
fraction containing expressed hAR for 30 minutes at 4°C
in the presence of 1 µM DHT and 0.4 M (NH4)2SO4 final
concentration. Another set of samples was processed
without ammonium sulfate during the binding step. After
incubation, samples were centrifuged for 30 seconds at
2000X g and supernatant (flow-through fraction) was
removed.The gel was washed twice with one bed volume
(50 µl) of wash buffer (100mM potassium phosphate pH
7.2, 0.15M NaCl, 1 µM of DHT, 10 mM
β-mercaptoethanol), followed by a third wash with 400
µl. Elution was performed in three steps by adding 150
µl (50 µl per step) of elution buffer: 100 mM potassium
phosphate, pH 7.2, 0.15 M NaCl, 1 µM DHT, 10 mM
β-mercaptoethanol, 2 mM D-biotin, incubating for 10
minutes at 4°C, spinning, then collecting the supernatant.
Purification of biotinylated hAR with the
Streptavidin Mutein Matrix using an ÄKTA™
purifier
Chromatography was performed on an ÄKTA™ purifier
using a Tricorn™ 5/50 column (Amersham Biosciences)
packed with 1 ml of Streptavidin Mutein Matrix.The
column was prepared according to the manufacturer’s
instructions, except that the equilibration buffer was
modified to 10 mM Tris-HCl, pH 8.0, 0.3 M NaCl.The
purification protocol included equilibration of the column
with 5 column volumes (CV) of equilibration buffer, loading
the nuclear-extract fraction containing biotinylated AR in
the nuclear-extract buffer, and washing the column with
10 CV of washing buffer: 20 mM Tris-HCl, pH 8.0, 0.15
M NaCl, 10% glycerol, 10 mM β-mercaptoethanol, 1 µM
DHT. Elution was performed with 10 CV of elution buffer:
50 mM Tris-HCl, pH 8.0, 0.2 M NaCl, 10% glycerol, 4 mM
DTT, 1 µM DHT, 5 mM D-biotin. All buffers were filtered
through 0.45 µm filters before use and chromatography
was performed at 0.2 ml/min flow rate at 4°C. One-milliliter
fractions were collected during the washing and elution
steps and analyzed by SDS-PAGE.
SDS-PAGE analysis of purified hAR
Expression and purification of hAR was monitored using
precast NuPage® Novex® Bis-Tris gels (Invitrogen) or
Criterion™ XT gels (Bio-Rad Laboratories) followed by
staining with SimplyBlue™ (Invitrogen) or blotting on
PVDF membranes (70V for 1.5 hours). Blotted
membranes were blocked with 5% low-fat milk in
phosphate-buffered saline (PBS) followed by washes with
PBST (PBS with 0.1% Tween®).The blots were
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conjugate and SuperSignal® West Pico kit.
Figure 2. Chromatogram of AR purification on an ÄKTA™ purifier
showing loading, washing, and elution steps. See text for details.
DNA binding assay
Costar 96-well plates were coated with 10 µg/well
neutravidin in 100 µl of 0.1M NaHCO3, pH 8.5 for 4 hr at
room temperature.Wells were blocked with 150 µl/well
of 2% milk in 0.1M NaHCO3, pH 8.5 for 1 hr at room
temperature and washed 5 times with 300 µl/well PBST
(PBS + 0.1% Tween 20). Biotinylated DNA (2pmol)
containing AR response element (ARE) in 100 µl of PBST
was added per well and incubated 1 hr at room
temperature. Remaining neutravidin sites were blocked
by adding 0.1mM biotin for 1 hr at room temperature.
Wells were washed 5 times with 300 µl PBST and either
100 µl of AR expressing Sf9 cell lysate or 1-2 µg of
purified AR in PBST was added in the presence of 1 µM
DHT. After overnight incubation at 4°C by gentle rotation,
the plate was washed 5 times with PBST and 20 µl of
NuPage 1X sample loading mix was added per well.The
plate was heated for 10 min at 95°C and samples were
analyzed by SDS-PAGE.
GST pull-down assay
AR cofactor ARA24 was cloned in the pDEST-15 vector
and expressed in BL21(DE3)pLysS cells as a GST-fusion
protein. pGEX-5X-1 vector, coding GST protein alone
(negative control), was also transformed and expressed
in BL21(DE3)pLysS cells. GST-fusion proteins were then
purified according to manufacturer’s instructions using
Glutathione Sepharose 4 Fast Flow beads . Purified
proteins were analyzed by SDS- PAGE to estimate protein
expression. GST protein was found to be expressed 5
times greater than GST-ARA24 (data not shown). For
GST pull-down assays, either 50 µl of GST-ARA24 or 10
µl of GST (with an additional 40 µl of bead slurry for 50
µl total) was used for each pull-down sample.
GST-proteins were incubated overnight at 4°C by gentle
rotation with AR expressing Sf9 cell lysate (100 µl) or with
2 µg purified AR in a total volume of 500 µl (adjusted with
cell lysis buffer) in the presence of 5 µM DHT. Following
incubation, beads were pelleted and washed 5 times with
cell lysis buffer (500 µl).The beads were resuspended
in 50 µl NuPage 2X sample loading buffer, heated for 5
min at 95°C, and analyzed by SDS-PAGE and western
blot.
Figure 3. Analysis of AR purification on an ÄKTA™ purifier by SDS
electrophoresis on a NuPage® NOVEX® Bis-Tris 4-12% gel
(SimplyBlue™ staining). M: Markers; F: flow-through fraction; lanes
C7 and C10: wash-step fractions; lanes C11 – D4: elution-step fractions.
A 15-µl aliquot from each fraction was loaded on the gel, with the exception
of the flow-through fraction lane, in which only 8 µl was loaded.
Results
Expression levels of hAR in Sf9 cells and the soluble AR
fraction were determined by western blot using
streptavidin-HRP to detect the biotinylated N-terminal tag
of AR. Full-length AR with a BAP tag (~ 26 amino acids)
migrated as a ~107 kDa band on SDS-PAGE and almost
all protein was retained in the soluble fraction (data not
shown).
Figure 4. Purified AR binds to DNA containing an androgen receptor
response element. (A) Western blot. 1: Precision Plus protein standards;
2: MagicMark™ Western standards; lanes 3,5,7 contain no DNA (ARE),
lanes 4,6,8 have 2 pmol ARE; 1mg of purified AR were used in lanes 3,4;
2mg of purified AR were used in lanes 5,6; AR expressing Sf9 cell lysate
was used in lanes 7,8. (B) same PVDF membrane used in (A) was stained
with MemCode™.
To explore the best binding conditions of AR to the
Streptavidin Mutein Matrix, we performed batch-method
purification in accordance with manufacturer’s
instructions, and analyzed protein purity by Western blot
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Methods Human AR purificationFigure 5. Recombinant AR interacts with ARA24 in vitro. (A) Western blot. 1: MagicMark™ Western standards; 2: Sf9 cell lysate with expressed
AR (1/40th of the input); 3: purified AR (1/4th of the input); 4 and 8: E.coli lysates with the over expressed GST and GST-ARA24 proteins respectively;
lanes 5-7 contains GST protein incubated in the absence of AR (lane 5), with AR expressing Sf9 lysate (lane 6) or purified AR (lane 7); lanes 9-11
contains GST-ARA24 protein incubated in the absence of AR (lane 9), with AR expressing Sf9 lysate (lane 10) or purified AR (lane 11); 12: Precision
Plus protein standards. (B) same PVDF membrane used in (A) was stained with MemCode™.
using streptavidin-HRP.The manufacturer’s
recommendation to perform binding in the presence of
0.4 M (NH4)2SO4 did not enhance AR binding to the
Streptavidin Mutein Matrix (Figure 1, lanes 2 versus 1
and 11 versus 10), and significantly reduced soluble AR
in the nuclear-extract fraction (lane 1 versus 10). Small
amounts of AR were detected in the wash fractions (lanes
3-5 and 12-14) and retained on the beads (lanes 9 and
19). However, more extensive elution resulted in the
removal of almost all AR from the matrix (data not shown).
We did not optimize the batch method for large scale
purification of AR; instead we optimized for use with an
automated FPLC method.We believe that these
conditions can be used for the batch method, if FPLC is
not available.This information is important as it bears on
the use of this system for other receptors.
For large-scale protein purification, we developed an
automated procedure using the ÄKTA™ purifier
chromatography system.The purification protocol
included three steps: (1) loading nuclear extract in
nuclear-extract buffer without the addition of ammonium
sulfate; (2) washing, and (3) elution with 10 CV of
appropriate buffers. A chromatogram of the purification
process showed a single peak representing AR in
fractions C11-D2 (Figure 2). Purified AR was
approximately 95% homogeneous as determined by an
SDS-PAGE gel stained with SimplyBlue™ (Figure 3) and
the yield was 2 mg of protein from 1 liter of infected Sf9
cell culture. Approximately 30% of the AR protein was
lost in the flow-through and wash-step fractions as
determined by western blot (data not shown).
We also performed several experiments to test the
functional activity of the purified AR protein. Using a DNA
binding assay developed in our laboratory [Norris et al.,
1999] , we demonstrated that purified AR binds to DNA
containing an androgen response element (ARE) (Figure
4A, lanes 3 - 6). For comparison, we also tested the ability
of AR expressed in the SF9 cell lysate to bind DNA
(Figure 4A, lanes 7,8 ). In both cases, AR was found to
be significantly enriched in wells containing DNA thus
confirming functional DNA binding activity of recombinant
AR. Also shown is a membrane stained for protein to
demonstrate the purity of the DNA bound AR (Figure 4B).
Next, we demonstrated that recombinant AR can interact
with ARA24, a known AR coactivator and interacting
protein. As shown in Figure 5A, recombinant AR, either
purified or from SF9 cell extract, interacts specifically with
GST-ARA24 and not with GST alone (compare lanes 6,7
with lanes 10,11). A membrane stained for protein is also
shown to allow for visualization of the GST proteins used
in this assay.These results demonstrate that recombinant
AR is functional with regard to coactivator binding. Several
other AR interacting proteins have been analyzed in this
assay and yielded similar results (data not shown).
Furthermore, purified AR remained stable through several
freeze/thaw cycles.We did not observe any protein
degradation by SDS-PAGE electrophoresis or any loss
of functional activity by DNA binding and GST pull-down
assays.We have not determined directly if the biotin tag
interferes with N-C terminal interaction. However, we
have demonstrated that biotinylated AR is active in
transcriptional studies (data not shown).This would
suggest that N-C terminal interaction is not disrupted by
the biotin tag.
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We have successfully applied this purification technique
to AR when bound to other ligands, AR domains (both
N- and C- terminus), and other full-length nuclear
receptors.We were not able to purify apo AR in significant
quantities since its expression level is greatly reduced
compared to ligand-bound AR (data not shown). Roche
Applied Science’s Streptavidin Mutein Matrix was found
to be superior for the purification of nuclear receptors
when compared to other resins that exploit
biotin-streptavidin interaction (Promega SoftLink™ Soft
Release Avidin and Pierce ImmunoPure Immobilized
Monomeric Avidin).The superior performance of the
Streptavidin Mutein Matrix is a result of low nonspecific
binding to the beads, efficient elution, low backpressure,
and ease of use with automated chromatography
systems.This technique allows the purification of AR in
a single step, yielding amounts sufficient for functional
and structural studies.
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